P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Relative Value

The Relative Value of one PharmaResearch Co Ltd stock under the Base Case scenario is 221 594.8 KRW. Compared to the current market price of 198 400 KRW, PharmaResearch Co Ltd is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
221 594.8 KRW
Undervaluation 10%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
63
Median 3Y
5
Median 5Y
5.1
Industry
7.7
Forward
6
vs History
1
vs Industry
8
Median 3Y
17.4
Median 5Y
18.9
Industry
22.7
Forward
19.9
vs History
12
vs Industry
9
Median 3Y
14.7
Median 5Y
17.2
Industry
21.6
vs History
33
vs Industry
7
Median 3Y
24
Median 5Y
31.2
Industry
25.2
vs History
0
vs Industry
29
Median 3Y
2.8
Median 5Y
2.6
Industry
2.5
vs History
0
vs Industry
56
Median 3Y
4.4
Median 5Y
4.6
Industry
7.7
Forward
5.5
vs History
0
vs Industry
49
Median 3Y
6.2
Median 5Y
6.5
Industry
9
vs History
0
vs Industry
9
Median 3Y
11.2
Median 5Y
12
Industry
4.2
Forward
13.5
vs History
3
vs Industry
8
Median 3Y
13.2
Median 5Y
15.1
Industry
4.1
Forward
14.8
vs History
11
vs Industry
10
Median 3Y
12.9
Median 5Y
15.2
Industry
5.7
vs History
38
vs Industry
7
Median 3Y
18.5
Median 5Y
23.4
Industry
3.6
vs History
0
vs Industry
38
Median 3Y
2.9
Median 5Y
2.6
Industry
4.6

Multiples Across Competitors

Competitors Multiples
PharmaResearch Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
PharmaResearch Co Ltd
KOSDAQ:214450
2T KRW 6.9 22.5 16.2 18.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
KR
P
PharmaResearch Co Ltd
KOSDAQ:214450
Average P/E: 177.3
22.5
97%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
P
PharmaResearch Co Ltd
KOSDAQ:214450
Average EV/EBITDA: 17
16.2
89%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
KR
P
PharmaResearch Co Ltd
KOSDAQ:214450
Average EV/EBIT: 21.9
18.2
99%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top